COVID-19 | United States

Date: Tuesday, November 2, 2021. 12:00 PM. Location: Zoom Webinar - RSVP Required On Tuesday, November 2, the Stanford King Center on Global Development will host a Speaker Series with Penny Goldberg, Elihu Professor of Economics, Yale University. Goldberg will discuss supply chain disruptions from the COVID-19 pandemic, including issues related to vaccine distribution. The discussion will be moderated by Pete Klenow, Landau Professor in Economic Policy, Stanford University.  The Series features talks by distinguished scholars and policymakers with the goal of fostering discussions about successes and challenges in the field of poverty alleviation.

Date: Thursday, October 14, 2021. 4:00 PM. Location: Via Zoom Webinar Register: https://bit.ly/3ulFdLi Professor Mobarak will discuss his research on COVID-19 response in Bangladesh and beyond, including masking, vaccine equity, and appropriate pandemic response policies in low and middle income countries. He will provide an overview of the coauthored MaskNorm study, a randomized-trial of community-level mask promotion in rural Bangladesh during COVID-19 that demonstrates a scalable and effective method to promote mask adoption and reduce symptomatic SARS-CoV-2 infections. He will also discuss efficient last-mile vaccine delivery in low-income countries and related research on the lower epidemiological and welfare value of social distancing in lower-income countries.

Date: Wednesday, October 13, 2021. 6:00 PM. Location: Zoom Description: This evening will be a special LASER, a fireside chat with Stanford virologist Catherine Blish on Covid-19 and the Virusphere. Register here:  https://stanford.zoom.us/webinar/register/WN_4mh9Hg4pSkO_hho6XM0pBA Catherine Blish is an Associate Professor of Medicine and Immunology at Stanford University School of Medicine and an Assistant Director of the Stanford Medical Scientist Training Program. Her clinical focus is on infectious diseases. She received her PhD in Immunology from the University of Washington School of Medicine, where she then pursued a fellowship in Infectious Disease, with a research focus on immune correlates of HIV-1 infection. Her current research aims to understand the successes and failures of the immune system in order to better harness it to prevent infections. Her lab is perhaps best known for redefining our understanding of the diversity of human natural killer cells, a critical first line of defense against vi...